AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20583949
Drug: Dutogliptin 400
RxNorm normalized name: Dutogliptin
DrugBank: Dutogliptin (DB11723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutogliptin 400 mg once daily and Metformin 1000 mg twice daily for 5 days
Trial: 15919161
Drug: Psychotherapy relapse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy relapse prevention treatment
Trial: 8898763
Drug: Hypertension defined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertension defined as systolic blood pressure ≥ 140 mmHg or diastolic pressure ≥ 90 mmHg or current use of antihypertensive medications
Trial: 6325994
Drug: sotalol, 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotalol, 320 or 960 mg/day
Trial: 19792989
Drug: Hydrochlorothiazide 12.5
RxNorm normalized name: hydrochlorothiazide 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 12.5 or 25 mg/day for 9 weeks
Trial: 15475095
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of more than 3 l of crystalloids during abdominal surgery
Trial: 15475095
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of more than 500 ml of colloids during abdominal surgery
Trial: 7742331
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine 10 micrograms
Trial: 7742331
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine 20 micrograms
Trial: 21613310
Drug: Mavrilimumab (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mavrilimumab (1.0 and 3.0 mg/kg)
Trial: 15193480
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of l-carnitine (2 g/d) and l-acetyl-carnitine (1 g/d)
Trial: 10958260
Drug: Antidepressants (imipramine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (imipramine, clomipramine, paroxetine)
Trial: 15338100
Drug: Diazepam 2.5
RxNorm normalized name: diazepam 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 2.5 mg
Trial: 6404954
Drug: Diazepam 5
RxNorm normalized name: diazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 5 mg
Trial: 6404954
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg
Trial: 29952189
Drug: PLF with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PLF with local bone graft with BM concentrate augmentation (BM group)
Trial: 22714033
Drug: Rectal indomethacin
RxNorm normalized name: indomethacin Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal indomethacin (100 mg suppository)
Trial: 22714033
Drug: Placebo (inert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inert suppository)
Trial: 20662716
Drug: Replication-defective adenovirus
RxNorm normalized name: COVID-19 VACCINE ADENOVIRUS-26
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Replication-defective adenovirus type 5 HIV-1 gag vaccine
Trial: 9549819
Drug: Palliative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palliative treatment in advanced cancer
Trial: 7605708
Drug: Weight-bearing exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight-bearing exercise (50 'heel drops' daily and weekly mixed exercise class)
Trial: 7605708
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (weekly low-impact exercise class and daily flexibility exercises)
Trial: 2178854
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg ranitidine (single dose)
Trial: 2178854
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg ranitidine (multiple doses, b.i.d. for 7 days)
Trial: 24328444
Drug: Quadrivalent influenza
RxNorm normalized name: influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injection [Fluzone Quadrivalent 2021-2022]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent influenza vaccine (QIV)
Trial: 21998698
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine
Trial: 31577041
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid (HA) gel treatment for 45 days
Trial: 17881751
Drug: Repeat courses
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeat courses of antenatal corticosteroids (betamethasone, 12 mg intramuscularly, repeated once at 24 hours)
Trial: 10841243
Drug: Warfarin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin alone
Trial: 11347790
Drug: Training intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training intervention (14-hour program in seven weekly 2-hour sessions)
Trial: 9783563
Drug: Intravenous clomipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous clomipramine (starting at 25 mg/d and increasing to 250 mg/d)
Trial: 9783563
Drug: Intravenous placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous placebo (initially randomized to receive i.v. placebo and treated subsequently with several days of open-label i.v. clomipramine)
Trial: 9783563
Drug: Intravenous clomipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous clomipramine (1 month after i.v. infusion)
Trial: 7945519
Drug: Ibuprofen lysinate
RxNorm normalized name: Ibuprofen Lysine
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen lysinate (IBL) 800 mg/d
Trial: 7945519
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 2000 mg/d
Trial: 16015665
Drug: Cyproheptadine hydrochloride
RxNorm normalized name: Cyproheptadine Hydrochloride
DrugBank: Cyproheptadine (DB00434)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyproheptadine hydrochloride (CH) 4 mg up to four times a day
Trial: 10383550
Drug: Bosentan 500
RxNorm normalized name: Bosentan
DrugBank: Bosentan (DB00559)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bosentan 500 mg twice daily for 1 week
Trial: 10383550
Drug: Digoxin 0.375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin 0.375 mg once daily for 13 days
Trial: 1879030
Drug: Tablet cucumber
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet cucumber vine compound
Trial: 1879030
Drug: Tablet hypotension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet hypotension compound (Control)
Trial: 7106164
Drug: Indapamide 2.5
RxNorm normalized name: indapamide 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indapamide 2.5 mg tablets
Trial: 29058298
Drug: All formulations
RxNorm normalized name: Novel Influenza-H1N1-09, all formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All formulations
Trial: 19540518
Drug: Metoclopramide, 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide, 0.2 mg/kg/dose q 6 hours
Trial: 19540518
Drug: Ranitidine, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, 2 mg/kg/dose q 8 hours
Trial: 15385355
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg of rocuronium based on real body weight (Group 1)
Trial: 11481696
Drug: Idazoxan 20
RxNorm normalized name: Idazoxan
DrugBank: Idazoxan (DB12551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idazoxan 20 mg
Trial: 8110564
Drug: i.v. fluids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. fluids (preloading with normal saline 16 ml kg‐1 and, if necessary, three subsequent boluses of 2.5 ml kg‐1)
Trial: 30932170
Drug: Granisetron (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (3 mg)
Trial: 8694322
Drug: Placebo (NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (NaCl 0.9%, 40 mL)
Trial: 1348167
Drug: Vecuronium repeated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium repeated injection
Trial: 15815895
Drug: Vecuronium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium infusion
Trial: 28391664
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract tablets (0.7 g, 0.05% green tea extract, equivalent to 1 mg polyphenols for three tablets)
Trial: 28391664
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets (identical to test tablets but without active agent)
Trial: 15087592
Drug: Shower PUVA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shower PUVA with trioxsalen (0.27 mg/l) for 10 min
Trial: 15087592
Drug: Shower PUVA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shower PUVA with trioxsalen (0.27 mg/l) for 5 min
Trial: 9855321
Drug: valspodar 400
RxNorm normalized name: VALSPODAR
DrugBank: Valspodar (DB11869)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valspodar 400 mg
Trial: 15198411
Drug: dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexamethasone 8 mg
Trial: 9855321
Drug: both drugs
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: both drugs concomitantly
Trial: 7738215
Drug: Intermittent famotidine
RxNorm normalized name: Famotidine
DrugBank: Famotidine (DB00927)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent famotidine (20 mg every 12 hr)
Trial: 7738215
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of cimetidine (1200 mg/24 hr)
Trial: 31797570
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation (branded)
Trial: 31109838
Drug: Cognitive behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioural therapy
Trial: 15648529
Drug: Parent Management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent Management Treatment (PMT) in the experimental group (E)
Trial: 8513955
Drug: Micronized progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized progesterone (200 mg) under fasting conditions
Trial: 8513955
Drug: Micronized progesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized progesterone (100, 200, or 300 mg) under fasting conditions
Trial: 3597168
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg caffeine
Trial: 27486873
Drug: Deferasirox treatment
RxNorm normalized name: Deferasirox
DrugBank: Deferasirox (DB01609)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Deferasirox treatment (mean daily dose 11.8 ± 7.0 mg/kg, mean duration 16 months)
Trial: 22219335
Drug: Acetazolamide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetazolamide (500 mg twice daily for 1 week)
Trial: 19473822
Drug: Cheese naturally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cheese naturally rich in cis-9, trans-11 CLA (200 g/week)
Trial: 15897376
Drug: Conservative acne
RxNorm normalized name: Propionibacterium acnes
DrugBank: Propionibacterium acnes (DB19089)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative acne therapy
Trial: 12849654
Drug: Class I
RxNorm normalized name: HLA class I antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Class I agents
Trial: 18769963
Drug: Alendronate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (10 mg/day for 3 years)
Trial: 12675021
Drug: Alendronate (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (any dose)
Trial: 7272177
Drug: Caroxazone 200
RxNorm normalized name: Caroxazone
DrugBank: Caroxazone (DB09254)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caroxazone 200 mg three times daily
Trial: 7272178
Drug: Caroxazone (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caroxazone (after discontinuation)
Trial: 24140678
Drug: Prasugrel with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel with low-dose aspirin (<150 mg)
Trial: 24140678
Drug: Prasugrel with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel with high-dose aspirin (≥150 mg)
Trial: 21884007
Drug: B-group vitamins
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: B-group vitamins (folic acid 1 mg, vitamin B12 0.4 mg, and B6 10 mg)
Trial: 19538242
Drug: Metformin 1
RxNorm normalized name: metformin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1 g orally without a SMM (fasting)
Trial: 18085140
Drug: Medicine cup
RxNorm normalized name: Ezy Dose Kids Medicine Cups
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine cup group (n = 47) treated with cupping therapy using a self-made medicine cup with 45 degrees C Chinese herb solution.
Trial: 8528851
Drug: Rapid i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid i.v. injection of famotidine
Trial: 8528851
Drug: Slow i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow i.v. infusion of famotidine
Trial: 1778319
Drug: Acellular DTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular DTP vaccine (25 micrograms PT)
Trial: 1778319
Drug: Acellular DTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular DTP vaccine (8 micrograms PT)
Trial: 8538704
Drug: Whole-cell DTP
RxNorm normalized name: ActHIB with Whole-Cell DTP Powder for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-cell DTP vaccine
Trial: 1778319
Drug: Acellular DTP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular DTP vaccines (both doses)
Trial: 1777371
Drug: Theophylline (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (250 mg)
Trial: 7213528
Drug: Aminophylline (390
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (390 mg)
Trial: 21782507
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus cetuximab
Trial: 17613279
Drug: Pentoxifylline (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (400 mg, orally twice daily with meals for one month)
Trial: 9790395
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg rectal misoprostol
Trial: 8538974
Drug: Telephone support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone support intervention (weekly calls throughout pregnancy)
Trial: 31225625
Drug: Reduced nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced nicotine content cigarettes (0.4, 2.4, 5.2, 15.8 mg/g)
Trial: 30287158
Drug: Sertraline and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline and olanzapine
Trial: 26162521
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone gel (TG) 80 mg daily for 4 days
Trial: 24284442
Drug: W25 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: W25 (25 g whey protein, 3.0 g leucine)
Trial: 24284442
Drug: W6 (6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: W6 (6.25 g whey protein, 0.75 g leucine)
Trial: 24284442
Drug: W6+Low‐Leu (6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: W6+Low‐Leu (6.25 g whey protein supplemented to 3.0 g total leucine)
Trial: 22871086
Drug: Pegaptanib sodium
RxNorm normalized name: Pegaptanib Sodium
DrugBank: Pegaptanib (DB04895)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegaptanib sodium 0.3 mg intravitreal injection
Trial: 18823228
Drug: Tryptophan supplements
RxNorm normalized name: Tryptophan
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tryptophan supplements (3 g per day for 14 days)
Trial: 17893438
Drug: Dexamethasone (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.6 mg/ml, maximum 16 mg) in a single dose
Trial: 11684376
Drug: Transdermal continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal continuous hormonal replacement therapy (HRT)
Trial: 3285878
Drug: Nifedipine 120
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine 120 mg/day
Trial: 18759767
Drug: PARMA 5
RxNorm normalized name: para-phenylenediamine
DrugBank: p-Phenylenediamine (DB14141)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PARMA 5 computer-assisted dosage
Trial: 15522941
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol (E2)
Trial: 9467549
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (E2)
Trial: 2069221
Drug: Heparin flush
RxNorm normalized name: heparin flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin flush twice daily
Trial: 31666828
Drug: Neostigmine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (1 mg)
Trial: 31666828
Drug: Dexmedetomidine (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (35 μg [0.5 μg/kg])
Trial: 31666828
Drug: Control (Lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Lidocaine 1.5% + Triamcinolone 40 mg/ml)
Trial: 27348904
Drug: Acupoint embedding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint embedding therapy applied to Ganshu (BL 18), Tai‐chong (LR 3), Fenglong (ST 40), Zusanli (ST 36), and Sanyinjiao (SP 6), once every 7 days for 6 months.
Trial: 27348904
Drug: Acupoint embedding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint embedding therapy group
Trial: 27348904
Drug: Polyene phosphatidylcholine
RxNorm normalized name: phosphatidylcholine, soybean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyene phosphatidylcholine capsules (essentiale), 228 mg/capsule, 2 capsules three times a day for 6 months.
Trial: 7009441
Drug: Indomethacin 100
RxNorm normalized name: indomethacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 100 mg/day
Trial: 1095133
Drug: Aspirin soluble
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin soluble 4 g/day
Trial: 1095133
Drug: Indomethacin and
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin and aspirin taken together
Trial: 18480831
Drug: Central augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Central augmentation index (CAI%)
Trial: 10772429
Drug: Levofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (500 mg qd x 5 d)
Trial: 20962623
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/day (started 3 days before coronary angiography)
Trial: 26516142
Drug: Chronic statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic statin therapy
Trial: 17396251
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg/day for 14 days (group A2)
Trial: 17396251
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (B1 and B2) receiving only pain-relieving therapy
Trial: 16223069
Drug: Moderate intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate intensity comprehensive behavioral treatment based on motivational interviewing and Cognitive Behavioral Therapy
Trial: 16223069
Drug: Standardized abstinence-oriented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized abstinence-oriented treatment
Trial: 7617248
Drug: Cefotetan (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotetan (average daily dose of 4 g in half of the cases and 6 g in the others, average treatment period of 8 days)
Trial: 3567124
Drug: Meptazinol (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meptazinol (1.5 mg/kg)
Trial: 3906942
Drug: Pethidine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine (1.5 mg/kg)
Trial: 29203068
Drug: Both dosing
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dosing intervals
Trial: 22695185
Drug: EGb-761 (Ginkgo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGb-761 (Ginkgo biloba) 240 mg per day for 12 weeks
Trial: 20521321
Drug: water plus
RxNorm normalized name: Premium Gripe Water Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: water plus 75 mg of caffeine
Trial: 9239586
Drug: Propofol Patient-Controlled
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol Patient-Controlled Sedation (PCS) - 0.5 mg/kg, lockout interval 3 min
Trial: 11421505
Drug: Metered dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metered dose inhaler (MDI) with terbutaline 1.5 mg (six puffs) and ipratropium 120 microg (six puffs) via six tidal breaths
Trial: 30132426
Drug: SAM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAM treatment plus flocculent/disinfectant water treatment